WebFind real-time EYPT - EyePoint Pharmaceuticals Inc stock quotes, company profile, ... Financials. Next reporting date: May 10, 2024: EPS forecast (this quarter)-$0.67: Annual revenue (last year) WebFeb 23, 2024 · EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, an …
EyePoint Pharmaceuticals - Funding, Financials, Valuation …
WebNov 3, 2024 · EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, announced financial results for the third quarter ended September 30, 2024 and highlighted recent corporate developments. Webeyepoint: [noun] the point at which the eye is placed in using an optical instrument (as a microscope) and which is coincident with the exit pupil of the instrument. state employees credit union black mountain
EyePoint Pharmaceuticals - PitchBook Data
WebTotal Cash Compensation information is comprised of yearly Base Pay and Bonuses. EyePoint Pharmaceuticals, Inc. income statements for executive base pay and bonus … WebMay 13, 2024 · EyePoint procured $2M revenues compared to $928K for the same period a year prior, thus representing a 115% increase. The revenues are comprised of sales from Dexycu ($684K) and Yutiq ($543K) plus ... WebMar 20, 2024 · WATERTOWN, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of ... state employees credit union carowinds